Related Experiment Video

Updated: Jun 4, 2025

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

431

Evaluation of the treatment effectiveness in children with coronavirus infection

Olesya M Horlenko1, Khrystyna A Hechko1, Lyubomyra B Prylypko1

  • 1UZHHOROD NATIONAL UNIVERSITY, UZHHOROD, UKRAINE.

Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego
|December 17, 2024
PubMed

Insights

Treatment for children with Coronavirus infection showed positive results, normalizing vitamin D3 and Zinc levels. Inflammatory markers significantly decreased post-treatment, indicating improved health outcomes.

Area of Science:

  • Pediatric infectious diseases
  • Immunology
  • Biochemistry

Background:

  • Coronavirus infection poses significant health risks to children, impacting various physiological markers.
  • Understanding treatment effectiveness is crucial for managing pediatric COVID-19 cases.

Purpose of the Study:

  • To evaluate the effectiveness of a treatment regimen in children diagnosed with Coronavirus infection.
  • To analyze changes in clinical and biochemical parameters following treatment.

Main Methods:

  • A study involving 68 children with confirmed Coronavirus infection, compared to a control group of 28.
  • Analysis of complete blood count (CBC), vitamin D3, Zinc, immunoglobulin levels, and inflammatory markers before and after treatment.

Main Results:

  • Treatment led to positive dynamics in most CBC parameters, except Platelets and Eosinophils.
  • Vitamin D3 and Zinc levels normalized, while immunoglobulin levels showed an initial increase followed by normalization.
  • Significant reductions were observed in inflammatory markers such as IL-1, IL-6, TNF-α, CRP, and D-dimer post-treatment.

Conclusions:

  • The studied treatment is effective in improving clinical and biochemical parameters in children with Coronavirus infection.
  • Treatment helps normalize key indicators and reduce inflammation, contributing to recovery.
  • Further monitoring indicated sustained positive trends and normalization of certain metabolic markers over six months.
Abstract

Keywords:
recurrent respiratory diseasesCoronavirus diseasechildrenclinical and laboratory dynamic examination≪post-COVID-19 syndrome≫

More Related Videos

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic09:03

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic

Published on: November 7, 2020

4.6K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.8K

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
298
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
123